Portage Biotech Announces Board Changes
Company Announcements

Portage Biotech Announces Board Changes

Portage Biotech (PRTG) has released an update.

Portage Biotech Inc. has announced the immediate resignations of board members Mark J. Simon, Linda M. Kozick, and Robert H. Glassman, M.D. The company has also appointed Jean-Christophe Renondin, M.D. and Justin Stebbing, M.D., Ph.D. to its board of directors, including roles on the Nominating and Audit Committees. The new appointments follow the company’s established compensation guidelines for non-employee directors.

For further insights into PRTG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskPortage Biotech Regains Nasdaq Compliance
TipRanks Auto-Generated NewsdeskPortage Biotech Reports Decreased Quarterly Loss
TheFlyPortage Biotech reports Q2 EPS ($1.58) vs. ($6.69) last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App